Ophthalmic drops

Co-Biosopt®

Brand Name:

Co-Biosopt®

Dosage:

2 % , 0.5 %

Generic Name:

Dorzolamide / Timolol

Pharmacotherapeutic Group:

Antiglaucoma agent

Therapeutic Indication:

Dorzolamide / Timolol: Co-Biosopt is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.

Dosage and Administration:

The dose is one drop of Co-Biosopt in the affected eye(s) two times daily.

Side Effects:

  • Cardiovascular: Angina, Bradyarrhythmia, Heart failure, Hypertension, Hypotension
  • Gastrointestinal: Nausea, Taste sense altered, Vomiting, Xerostomia
  • Neurologic: Dizziness, Headache
  • Ophthalmic: Blepharitis, Blurred vision, Burning sensation in eye, Conjunctival hyperemia, Excessive tear production, Itching of eye, Light intolerance, Pain in eye
  • Psychiatric: Depression
  • Respiratory: Bronchitis, Dyspnea, Nasal congestion, Upper respiratory infection

 

Copyright © 2019 Bakhtar Bioshimi Co, All rights reserved.